Marianne P. Allen

Array ( [id] => 7409004 [patent_doc_number] => 20040019919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Calcium binding proteins' [patent_app_type] => new [patent_app_number] => 10/380705 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 28473 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019919.pdf [firstpage_image] =>[orig_patent_app_number] => 10380705 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 638937 [patent_doc_number] => RE039355 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2006-10-17 [patent_title] => 'Preparation of human IGF via recombinant DNA technology' [patent_app_type] => reissue [patent_app_number] => 10/461712 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 27 [patent_no_of_words] => 15273 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/039/RE039355.pdf [firstpage_image] =>[orig_patent_app_number] => 10461712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 699675 [patent_doc_number] => 07067631 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-27 [patent_title] => 'Fused DNA sequence, fused protein expressed from said fused DNA sequence and method for expressing said fused protein' [patent_app_type] => utility [patent_app_number] => 10/457372 [patent_app_country] => US [patent_app_date] => 2003-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 8070 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/067/07067631.pdf [firstpage_image] =>[orig_patent_app_number] => 10457372 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7133709 [patent_doc_number] => 20040043076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Prolonged release microspheres for injection delivery and preparation method' [patent_app_type] => new [patent_app_number] => 10/296314 [patent_app_country] => US [patent_app_date] => 2003-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4247 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043076.pdf [firstpage_image] =>[orig_patent_app_number] => 10296314 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 202674 [patent_doc_number] => 07632809 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-15 [patent_title] => 'Multimeric ligands with enhanced stability' [patent_app_type] => utility [patent_app_number] => 10/419976 [patent_app_country] => US [patent_app_date] => 2003-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10470 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/632/07632809.pdf [firstpage_image] =>[orig_patent_app_number] => 10419976 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 322452 [patent_doc_number] => 07517684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-14 [patent_title] => 'Nucleic acid and amino acid sequences relating to Pseudomonas aeruginosa for diagnostics and therapeutics' [patent_app_type] => utility [patent_app_number] => 10/419128 [patent_app_country] => US [patent_app_date] => 2003-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28073 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/517/07517684.pdf [firstpage_image] =>[orig_patent_app_number] => 10419128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7394416 [patent_doc_number] => 20040038397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'Alzheimer model for drug screening' [patent_app_type] => new [patent_app_number] => 10/414829 [patent_app_country] => US [patent_app_date] => 2003-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4806 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038397.pdf [firstpage_image] =>[orig_patent_app_number] => 10414829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7364518 [patent_doc_number] => 20040005602 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'DNA encoding the vertebrate homolog of hedgehog, Vhh-1, expressed by the notocord, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/411927 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 80 [patent_figures_cnt] => 80 [patent_no_of_words] => 45875 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 10411927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5922386 [patent_doc_number] => 20060240484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-26 [patent_title] => 'Protein for diagnosing diabetic retinopathy' [patent_app_type] => utility [patent_app_number] => 10/521675 [patent_app_country] => US [patent_app_date] => 2003-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2644 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0240/20060240484.pdf [firstpage_image] =>[orig_patent_app_number] => 10521675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6983346 [patent_doc_number] => 20050153416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Conjugates of the c domain of human gelatinase a and polyethylene glycol, methods of purification and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/505990 [patent_app_country] => US [patent_app_date] => 2003-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7286 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20050153416.pdf [firstpage_image] =>[orig_patent_app_number] => 10505990 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6825220 [patent_doc_number] => 20030235842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-25 [patent_title] => 'Map' [patent_app_type] => new [patent_app_number] => 10/374606 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14880 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20030235842.pdf [firstpage_image] =>[orig_patent_app_number] => 10374606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7451363 [patent_doc_number] => 20040010117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-15 [patent_title] => 'Streptoccal inhibitor of complement-mediated lysis, protein SIC' [patent_app_type] => new [patent_app_number] => 10/374535 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10072 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20040010117.pdf [firstpage_image] =>[orig_patent_app_number] => 10374535 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 798007 [patent_doc_number] => 07427594 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-09-23 [patent_title] => 'Methods and pharmaceuticals compositions for treating coronary artery disease, ischemia,and vascular disease using angiopoietins' [patent_app_type] => utility [patent_app_number] => 10/375765 [patent_app_country] => US [patent_app_date] => 2003-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 15118 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427594.pdf [firstpage_image] =>[orig_patent_app_number] => 10375765 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6769472 [patent_doc_number] => 20030215412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Induction of hair growth with vascular endothelial growth factor' [patent_app_type] => new [patent_app_number] => 10/370830 [patent_app_country] => US [patent_app_date] => 2003-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12715 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215412.pdf [firstpage_image] =>[orig_patent_app_number] => 10370830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6701608 [patent_doc_number] => 20030224488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-12-04 [patent_title] => 'Materials and methods for preparing dimeric growth factors' [patent_app_type] => new [patent_app_number] => 10/365095 [patent_app_country] => US [patent_app_date] => 2003-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12269 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20030224488.pdf [firstpage_image] =>[orig_patent_app_number] => 10365095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843048 [patent_doc_number] => 20030148395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Method for identifying JNK and MLK inhibitors for treatment of neurological conditions' [patent_app_type] => new [patent_app_number] => 10/360463 [patent_app_country] => US [patent_app_date] => 2003-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13026 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148395.pdf [firstpage_image] =>[orig_patent_app_number] => 10360463 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7097828 [patent_doc_number] => 20050130287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Purifying process of soluble proteins of the l.obliqua bristles through prothrombin activation: process for a partial determination of the amino acids sequence of the prothrombin activator; process for determining the prothrombin activation of fraction II, n-terminal and internal fragments sequences' [patent_app_type] => utility [patent_app_number] => 10/501238 [patent_app_country] => US [patent_app_date] => 2003-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8569 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130287.pdf [firstpage_image] =>[orig_patent_app_number] => 10501238 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6634428 [patent_doc_number] => 20030211548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Visualization and quantitiation of cellular cytotoxicity using cell-permeable fluorogenic protease substrates and caspase activity indicator markers' [patent_app_type] => new [patent_app_number] => 10/353791 [patent_app_country] => US [patent_app_date] => 2003-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14954 [patent_no_of_claims] => 111 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0211/20030211548.pdf [firstpage_image] =>[orig_patent_app_number] => 10353791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7432265 [patent_doc_number] => 20040002084 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-01 [patent_title] => 'Nucleic acids, polypeptides, vectors, and cells derived from activated eosinophil cells' [patent_app_type] => new [patent_app_number] => 10/350923 [patent_app_country] => US [patent_app_date] => 2003-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28566 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20040002084.pdf [firstpage_image] =>[orig_patent_app_number] => 10350923 [rel_patent_id] =>[rel_patent_doc_number] =>)